Amaya says the Division of Gaming Enforcement’s review of PokerStars was a detailed one, and included sworn interviews with more than 70 individuals and visits to approximately a half dozen international jurisdictions.
“We are very pleased to add New Jersey to the long list of regulated markets that have found PokerStars and Full Tilt suitable to offer real-money on-line gaming,” said CEO David Baazov. “I want to thank the DGE for their thorough and fair review of our business. We look forward to bringing our popular brands, innovative technology, marketing prowess and world-class security, and game integrity to the growing New Jersey on-line gaming market. We anticipate providing additional details of our launch plans in the near future.”
Dundee Capital markets analyst Eyal Ofir recently speculated that Amaya could rally if granted New Jersey gaming license, in part because some were betting against the Canadian firm.
“We view a New Jersey license as a major catalyst for the stock for two prime reasons: a) Although NJ is not material financially, it will set a precedent and be the first US State allowing PokerStars to enter the market; and b) there are numerous hedge funds that are betting against Amaya’s ability to get licensed and have short positions. We believe this creates a solid risk/reward trading opportunity,” he said.
Last June, Amaya completed the transformational $4.9-billion acquisition of the Oldford Group, which owned the PokerStars and Full Tilt Poker brands.
In 2013, New Jersey became the third state, after Nevada and Delaware, to legalize online gambling. Some speculate that several more states, including Rhode Island, Connecticut, Illinois, Ohio, New York and California may join Nevada, Delaware and New Jersey in legalizing online gambling.
At press time, shares of Amaya on the TSX were up 14.5% to $27.87.
Organigram (Organigram Global Stock Quote, Chart, News, Analysts, Financials TSX:OGI) reported fiscal Q3 2025 results for the period ended June… [Read More]
Electrovaya (Electrovaya Stock Quote, Chart, News, Analysts, Financials NASDAQ:ELVA) delivered strong fiscal Q3 2025 results, its second GAAP-profitable quarter and… [Read More]
Leede Financial analyst Douglas Loe said Aug. 13 that Medexus Pharmaceuticals’ (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP)… [Read More]
Beacon Securities analyst Gabriel Leung noted in an August 12 watchlist update that Hydreight Technologies (Hydreight Technologies Stock Quote, Chart,… [Read More]
Research Capital’s Andre Uddin said August 13 he remains focused on Eupraxia Pharmaceuticals’ (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts,… [Read More]
National Bank Financial Markets analyst Richard Tse said Aug. 12 that reports of Altus Group (Altus Group Stock Quote, Chart,… [Read More]